The safety of treatment options for pediatric Crohn's disease.

about

Treating children with inflammatory bowel disease: Current and new perspectives.Short-Term Outcome of Infliximab Therapy in Pediatric Crohn's Disease: A Single-Center Experience.The current therapeutic options for Crohn's disease: from medical therapy to intestinal transplantation.

P2860

Q38602911-3A3636FE-3978-4255-994E-2E1B8ACAC160 Q47160953-21644EA6-C5F9-4096-A7F1-AEF857A13D37 Q47798734-320B235A-14CA-4AFC-BD40-61F964091F01

P2860

The safety of treatment options for pediatric Crohn's disease.

Item

http://www.wikidata.org/entity/Q38883237

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The safety of treatment options for pediatric Crohn's disease.

@en

type

Item

label

The safety of treatment options for pediatric Crohn's disease.

@en

prefLabel

The safety of treatment options for pediatric Crohn's disease.

@en

P1476

The safety of treatment options for pediatric Crohn's disease.

@en

P2093

Jeffrey S Hyams

http://www.w3.org/2001/XMLSchema#string

Victoria Grossi

http://www.w3.org/2001/XMLSchema#string

P2860

Azathioprine and UVA light generate mutagenic oxidative DNA damage

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease

Structure and dynamics of thioguanine-modified duplex DNA

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy.

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease

P304

1383-1390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14740338.2016.1203418

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27367297

http://www.w3.org/2001/XMLSchema#string

The safety of treatment options for pediatric Crohn's disease.

about

P2860

P2860

The safety of treatment options for pediatric Crohn's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698